- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03224247
Vertical Splitting of Muscle Layer in Lower Segment Cesarean Sections to Avoid Uterine Vessels Injury
Comparison Between Vertical Splitting Versus Transverse Cutting of Muscle Layer in Lower Segment Cesarean Sections to Avoid Uterine Vessels Injury: a Randomized Controlled Trial
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Cesarean section is one of the oldest surgical interventions in the history of medicine.Since the first documented cesarean delivery in 1020 AD, various modifications have been made in the technique. It was a surgery performed as a last resort, mostly peri- or post-portem.
Many variations in cesarean section technique have been studied.our study aim is to decrease blood loss during cesarean section through decreasing incidence of uterine vessels injury. The investigator supposed that applying Vertical pull on a small C-shaped incision in the lower uterine segment during cesarean section allows the tissues to split along their natural arrangement, decreasing the probability of extension of the wound into the uterine vessels, thus; decreasing blood loss; operative time and maternal recovery.
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Cairo, Egipto, 11311
- Ahmed Abass
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Elective cesarean section
- No medical disorders during pregnancy ( Hypertension, DM , ..)
- No coagulation disorders either congenital nor acquired.
Exclusion Criteria:
- Urgent or emergency cesarean section.
- Multiple pregnancy.
- Presence of medical disorders during pregnancy ( Hypertension, DM , ..)
- Presence of coagulation disorders either congenital nor acquired.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Comparador activo: Transverse splitting
transverse cutting and/or pulling of lower uterine segment during lower segment cesarean section.
|
Transverse cutting and/or pulling.of
lower uterine segment during lower cesarean section extending the uterine incision laterally.
|
Comparador activo: Vertical splitting
vertical splitting,of lower uterine segment during lower segment cesarean section.
|
vertical splitting of lower uterine segment during lower cesarean section making the direction of traction up and downward instead of being laterally and we suppose that this will allow the tissues to split along their natural arrangement, decreasing the probability of extension of the wound into the uterine vessels, thus; decreasing blood loss; operative time and maternal recovery.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Uterine vessels injury
Periodo de tiempo: 1 minute after extraction of the baby and placenta
|
the surgeon performing the cesarean section will detect if injury of uterine vessels occurred or not while extending uterine incision.
|
1 minute after extraction of the baby and placenta
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
uterine incision extension
Periodo de tiempo: 2 minutes extraction of the baby and placenta
|
the surgeon performing the cesarean section will detect if uterine incision extension occurred or not after extraction of the baby and the placenta.
|
2 minutes extraction of the baby and placenta
|
intra-operative blood loss
Periodo de tiempo: before closure of the abdominal wall layer
|
blood loss will be assessed by circulating nurse through counting soaked surgical towels and gauze and calculating estimated blood loss in vacation suction system.
|
before closure of the abdominal wall layer
|
postpartum hemorrhage
Periodo de tiempo: first 24 hours after delivery
|
will be defined by postpartum blood loss of 1000cc
|
first 24 hours after delivery
|
postoperative pain
Periodo de tiempo: 2 hours after delivery
|
pain scale from 0 to 10 to assess postoperative pain after delivery
|
2 hours after delivery
|
postoperative pain
Periodo de tiempo: 6 hours after delivery
|
pain scale from 0 to 10 to assess postoperative pain at hours 2 after delivery
|
6 hours after delivery
|
postoperative pain
Periodo de tiempo: 12 hours after delivery
|
pain scale from 0 to 10 to assess postoperative pain at hours 2 after delivery
|
12 hours after delivery
|
postoperative pain
Periodo de tiempo: 24 hours after delivery
|
pain scale from 0 to 10 to assess postoperative pain at hours 2 after delivery
|
24 hours after delivery
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Director de estudio: Waled Hitler, Prof, Ainshams university
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- Vertical splitting in CS
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .